Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-03-06 Purchase | 2023-03-08 4:07 pm | CASSAVA SCIENCES INC | SAVA | Barry Richard Director | 88,841 | $25.81 | $2,292,823 | 275,000 (Indirect) | View |
2022-08-23 Purchase | 2022-08-25 4:20 pm | CASSAVA SCIENCES INC | SAVA | Barry Richard Director | 36,159 | $23.79 | $860,223 | 186,159 (Indirect) | View |
2020-08-07 Sale | 2020-08-07 8:00 pm | Sarepta Therapeutics Inc. | SRPT | Barry Richard Director | 30,000 | $158.5 | $4,754,972 | 3,129,140 (Direct) | View |
2020-05-15 Sale | 2020-05-15 9:02 pm | Sarepta Therapeutics Inc. | SRPT | Barry Richard Director | 30,000 | $141.26 | $4,237,946 | 3,159,140 (Direct) | View |
2019-09-12 Purchase | 2019-09-16 08:00 am | Sarepta Therapeutics Inc. | SRPT | Barry Richard Director | 5,000 | $87.49 | $437,455 | 3,187,065 (Direct) | View |
2019-08-20 Purchase | 2019-08-20 5:43 pm | Sarepta Therapeutics Inc. | SRPT | Barry Richard Director | 5,000 | $99.32 | $496,593 | 3,182,065 (Direct) | View |
2019-08-14 Purchase | 2019-08-14 4:38 pm | Sarepta Therapeutics Inc. | SRPT | Barry Richard Director | 3,700 | $122.5 | $453,250 | 3,177,065 (Direct) | View |
2019-08-12 Purchase | 2019-08-13 4:31 pm | Sarepta Therapeutics Inc. | SRPT | Barry Richard Director | 1,300 | $122.5 | $159,250 | 3,173,365 (Direct) | View |
2018-06-27 Sale | 2018-06-29 6:01 pm | Sarepta Therapeutics Inc. | SRPT | Barry Richard Director | 75,000 | $130.34 | $9,775,500 | 3,170,432 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2023-03-06 Option Award | 2023-03-08 8:00 pm | 2024-03-06 2033-03-06 | Sarepta Therapeutics Inc. | SRPT | Barry Richard Director | 4,780 | $0 | 3,133,099 (Direct) | View |
2022-03-07 Option Award | 2022-03-08 8:03 pm | 2023-03-07 2032-03-07 | Sarepta Therapeutics Inc. | SRPT | Barry Richard Director | 8,030 | $0 | 3,133,396 (Direct) | View |
Ownership | 2021-06-14 4:22 pm | N/A N/A | CASSAVA SCIENCES INC | SAVA | Barry Richard Director | 0 | $0 | 150,000 (Indirect) | View |
2021-03-03 Option Award | 2021-03-05 8:01 pm | 2022-03-03 2031-03-03 | Sarepta Therapeutics Inc. | SRPT | Barry Richard Director | 8,244 | $0 | 3,130,884 (Direct) | View |
2020-08-10 Ownership | 2021-02-12 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Barry Richard Director | 6,500 | $0 | 3,122,640 (Direct) | View |
2020-08-05 Option Award | 2020-08-06 4:36 pm | N/A N/A | MIMEDX GROUP INC. | MDXG | Barry Richard Director | 38,135 | $0 | 3,338,135 (Indirect) | View |
2020-02-28 Option Award | 2020-02-28 8:04 pm | 2021-02-28 2030-02-28 | Sarepta Therapeutics Inc. | SRPT | Barry Richard Director | 5,760 | $0 | 3,192,825 (Direct) | View |
Ownership | 2019-06-28 2:38 pm | N/A N/A | MIMEDX GROUP INC. | MDXG | Barry Richard Director | 0 | $0 | 3,300,000 (Indirect) | View |
2019-03-04 Option Award | 2019-03-04 8:01 pm | N/A 2029-03-04 | Sarepta Therapeutics Inc. | SRPT | Barry Richard Director | 4,846 | $0 | 3,175,278 (Direct) | View |